Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Empagliflozin Versus Placebo on the Rate of Arrhythmic Events in Heart Failure Patients

NCT03271879 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT03271879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03271879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Empagliflozin Versus Placebo on the Rate of Arrhythmic Events in Heart Failure Patients
Lead sponsor
Rambam Health Care Campus
Phase
Phase 4
Overall status
Unknown status
Start date
February 15, 2018
Completion date
June 1, 2020
Enrollment
128 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arrythmia, diabetes mellitus, heart failure